Horizon Pharma, Covidien sales and marketing update

Horizon granted Covidien's Mallinckrodt LLC pharmaceutical business non-exclusive rights to co-promote Duexis ibuprofen/famotidine in the U.S. through Dec. 31, 2014, for the relief of signs and sympt...